Extranodal Non-Hodgkin Lymphoma — Trials

Extranodal Non-Hodgkin Lymphoma — Trials · CancerIndex

Clinical trials

Registered studies

261 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 46
Recruiting: 18
Ph III recruiting: 1
Growth YoY: —
Industry share: 13%
Top sponsor: Ruijin Hospital
Termination share: 32.9%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (43)

clinicaltrialsPublishedShowing 1–3 of 3 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05426824	The Whole-course Management of Pegaspargase in ENKTL	unknown	N/A	72	The First Affiliated Hospital with Nanjing Medical UniversityOTHER	1	Jun 22, 2022	clinicaltrials
NCT03051542	Evaluating 18F-FDG PET/CT With Liver SUVmax-based Criteria for Prognosis of Patients With Natural Killer/T-cell Lymphoma	unknown	N/A	60	Peking University Cancer Hospital & InstituteOTHER	1	Feb 13, 2017